Once again a lot of "duh" at ePharma summit

Feb/09/2010 08:50

Just when I think there is hope for Internet health marketing they pull me back in ! I have been following the ePharma summit via Twitter and the revelations coming from presentations are a lesson in DUH ! Read More...

Tags: Duh

|

Mobile applications from Sanofi

Feb/09/2010 06:26

Imagine you're on the road and trying to eat right. Sanofi's GoMeals™ makes it easy to access nutritional information, find restaurants and keep track of your food intake. If you have a health condition like diabetes, knowing information like calories, fats and carbs can be critical. GoMeals was developed to help consumers get the information they need to make better meal choices at home or on the go. This is a great app but this is just the start of a lot of mobile tools to come if pharma can prepare for the future and anticipate the opportunities of mobile apps plus the Apple tablet. Read More...

Tags: Mobile applications

|

Acknowledge how Americans' trust has been lost and take the first steps to earn it back.

Feb/09/2010 05:37

"For years, Wall Street CEOs have thrown away customer trust like so much worthless trash". This quote could easily be applied to the pharma and medical device industries. It's always been about getting new customers while current customers languish in a world of misinformation and hiding behind data. Can pharma & medical device companies regain trust? Yes but they need some new marketing linchpins to break out of current thinking. Read More...

|

FDA Ad Division Objects To User-Friendly Efficacy Claims With Jargon

Feb/08/2010 09:30

Another barrier to social media use by pharma? The FDA expects drug advertisements to use the same level of language to convey both safety and efficacy information, according to a pair of letters from the Division of Drug Marketing, Advertising and Communications. In both a Jan. 26 letter regarding Meda's Astelin and a Jan. 22 letter for Novalar's OraVerse , FDA's ad enforcement division took issue with the use of user-friendly language for the efficacy claims while the risk information was presented using less-clear scientific terminology. Even if it's easier to understand for consumers and patients. Read More...

Tags: Content